In this episode of the Life Science Success Podcast, host Don Davis, PhD, MBA, sits down with Dr. Patrick Hurley, VP of Marketing at EndoSound, to explore the cutting-edge world of endoscopic ultrasound technology. Dr. Hurley brings a wealth of experience to the conversation, with 13 years in product and market management in the medical device industry and a Ph.D. in biology specializing in neuroscience.

Listeners will gain insights into Dr. Hurley's journey from academia to the medical device industry, and how his background in neuroscience has influenced his career in marketing. The discussion delves into EndoSound's innovative approach to endoscopic ultrasound technology and its potential impact on patient care and the field of gastroenterology.

Dr. Hurley shares his expertise on building successful marketing strategies in the medical device sector, particularly in the GI space. He discusses the challenges and opportunities in launching new GI products and building strong relationships with key opinion leaders in the gastroenterology community

In this episode of Life Science Success, we welcome Ani Sinha, the Vice President of Commercial Operations at Shionogi Inc. Ani brings nearly 15 years of deep commercial expertise in the pharmaceutical and biotech industries. She shares her inspiring journey from studying microbiology and biochemistry at Yale and Columbia to holding strategic leadership roles at companies like Pfizer, Bayer, and Celgene. We delve into her current role at Shionogi, exploring how she leads functions like Analytics and Insights, Market Research, and Field Operations. Ani discusses the innovative projects she's excited about and how they're contributing to Shionogi's mission. She also shares the greatest piece of leadership advice she's ever received and opens up about what inspires, concerns, and excites her in the world of life sciences. Tune in to gain valuable career insights and explore the dynamic future of pharmaceutical advancements.

In this episode of Life Science Success, we dive deep with Dr. John L. LaMattina, former president of Pfizer Global R&D and current biotech industry leader. From groundbreaking drug discoveries to shaping the future of pharmaceuticals, Dr. LaMattina shares his journey from the lab to the boardroom. Gain unique insights into innovation, challenges, and opportunities in life sciences as we explore the ever-evolving world of drug development. Whether you're an industry professional or simply curious about the future of healthcare, this conversation promises to inform and inspire.

Nishtha Jain is a strategic thought leader with over 14 years of experience in global information technology, specializing in digital technology transformations and innovation strategies within the life sciences sector. As the Head of Innovation and Digital Technology at Takeda Pharmaceuticals, she drives digital and data initiatives to enhance global R&D quality and is actively involved in diversity, equity, and inclusion efforts.

In this episode of the Life Science Success Podcast, my guest is Dr. Zachary S. Brooks, a serial entrepreneur, #1 Best Selling Author, and founder of UGenome AI. Dr. Brooks brings a wealth of experience from his diverse background in technology startups, financial services, and digital authentication. As the founder of UGenome AI, he's at the forefront of developing innovative SaaS tools for genomic medicine. We'll explore his journey from studying bilingual decision-making to becoming a leader in the life sciences field, and discuss how his experiences as an international athlete and multilingual individual have shaped his approach to business and innovation. Dr. Brooks will share insights on the future of personalized medicine, the intersection of genomics and organ transplantation, and the challenges of bringing cutting-edge technology to market. We'll also delve into his work with World Transplant Athletes and his vision for improving healthcare outcomes for organ transplant recipients. This episode promises to be an inspiring and informative conversation about the exciting developments in genomic medicine and the power of entrepreneurship in the life sciences.

In this episode of the Life Science Success Podcast, my guest is Dr. Vlad Vitoc, Chairman of the Board, CEO, and President of MAIA Biotechnology. Dr. Vitoc shares his journey from practicing medicine in Romania to leading a cutting-edge biotech company in the United States. We explore MAIA Biotechnology's innovative approach to cancer treatment, focusing on telomere-targeting therapeutics and their lead compound, THIO. Dr. Vitoc offers insights into the challenges of developing new cancer therapies, the future of targeted treatments, and how his international background influences his leadership style.

He also discusses the balance between scientific innovation and commercial viability in the biotech industry. This episode provides a fascinating look into the intersection of medical expertise, business acumen, and scientific innovation in the fight against cancer.

In this episode of the Life Science Success Podcast, my guest is Dr. Russ Lebovitz. Dr. Lebovitz is a seasoned expert in the life sciences, with over 15 years of experience as a senior scientist and research physician. He has served on the faculties of Baylor College of Medicine and The Fox Chase Cancer Center. Transitioning from academia to industry, he has led biotech companies in the diagnostics field, focusing on early detection of neurodegenerative diseases. As the CEO of Amprion, Dr. Lebovitz is pioneering innovative technologies to revolutionize brain health. He collaborates with organizations like the Alzheimer's Drug Discovery Foundation and the Michael J. Fox Foundation to advance research and awareness. Join us as we delve into his remarkable journey and the groundbreaking work he's doing to transform the future of diagnostics.

In this episode of Life Science Success, my guest is Michelle Briscoe, the Chief Operating Officer and Chief Financial Officer of Talus Bio. We dive into Michelle's extensive 26-year career in leading scientific organizations and her current role at Talus Bio. Michelle shares insights on the company's innovative MARMOT platform for drug discovery, targeting "undruggable" transcription factors. We explore her strategies for creating exceptional workplaces, her experience with M&A, and her co-founding of OUTbio Seattle. Michelle also discusses balancing financial and operational demands in biotech, industry trends, and her leadership philosophy.